iTeos Therapeutics, Inc. (DELISTED) (ITOS:DL)
10.15
0.00 (0.00%)
USD |
NASDAQ |
Sep 05, 16:00
iTeos Therapeutics Enterprise Value : -61.62M for Sept. 5, 2025
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 05, 2025 | -61.62M |
| September 04, 2025 | -61.62M |
| September 03, 2025 | -61.62M |
| September 02, 2025 | -61.62M |
| August 29, 2025 | -61.62M |
| August 28, 2025 | -61.62M |
| August 27, 2025 | -62.50M |
| August 26, 2025 | -62.50M |
| August 25, 2025 | -62.50M |
| August 22, 2025 | -59.85M |
| August 21, 2025 | -59.41M |
| August 20, 2025 | -58.96M |
| August 19, 2025 | -62.50M |
| August 18, 2025 | -63.39M |
| August 15, 2025 | -63.39M |
| August 14, 2025 | -63.39M |
| August 13, 2025 | -62.94M |
| August 12, 2025 | -63.83M |
| August 11, 2025 | -63.39M |
| August 08, 2025 | -63.39M |
| August 07, 2025 | -62.50M |
| August 06, 2025 | -63.39M |
| August 05, 2025 | -63.39M |
| August 04, 2025 | -64.05M |
| August 01, 2025 | -64.27M |
| Date | Value |
|---|---|
| July 31, 2025 | -62.41M |
| July 30, 2025 | -63.29M |
| July 29, 2025 | -63.73M |
| July 28, 2025 | -63.73M |
| July 25, 2025 | -61.08M |
| July 24, 2025 | -61.96M |
| July 23, 2025 | -62.85M |
| July 22, 2025 | -63.29M |
| July 21, 2025 | -62.85M |
| July 18, 2025 | -57.11M |
| July 17, 2025 | -57.11M |
| July 16, 2025 | -56.22M |
| July 15, 2025 | -54.90M |
| July 14, 2025 | -53.17M |
| July 11, 2025 | -55.82M |
| July 10, 2025 | -59.35M |
| July 09, 2025 | -58.47M |
| July 08, 2025 | -63.33M |
| July 07, 2025 | -65.54M |
| July 03, 2025 | -60.68M |
| July 02, 2025 | -61.56M |
| July 01, 2025 | -68.63M |
| June 30, 2025 | -69.95M |
| June 27, 2025 | -134.49M |
| June 26, 2025 | -131.81M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ZimVie, Inc. (DELISTED) | 700.09M |
| Sarepta Therapeutics, Inc. | 2.130B |
| Black Titan Corp. | -- |
| Solid Biosciences, Inc. | 264.18M |
| Replimune Group, Inc. | 879.05M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -78.73M |
| Total Expenses (Quarterly) | 78.73M |
| EPS Diluted (Quarterly) | -1.807 |
| Earnings Yield | -46.21% |
| Normalized Earnings Yield | -47.83 |